Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
primepeptides.co
Prime Peptides holds a Disclosed Labs trust grade of C (72/100), computed independently from 53 lab Certificates of Analysis (as of July 2026). That's a solid, verifiable track record. Scores come only from lab COAs; vendors can't pay to raise them.
What is Prime Peptides's trust score?
Prime Peptides scores 72/100 (Grade C) on Disclosed Labs, from 53 lab COAs (as of July 2026).
How is Prime Peptides's trust score calculated?
Only from lab-issued Certificates of Analysis — average purity, safety-panel coverage, lab corroboration, and forgery signals. No vendor can pay to change it, and sponsorships never affect it.
Samples
Passed
Failed
Trust score updated: July 6, 2026 · 100% pass rate
Composite score based on 53 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of the safety panels each product form requires — identity, net-content, heavy-metals and residual-solvents for raw powders, plus endotoxin and sterility for injectables. Forms aren't penalized for panels they don't need.
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Operates as Prime Vitality Inc out of Santa Barbara, CA; ships from California via FedEx 2 Day Air.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| Jun 25, 2026 | BPC-157 / Thymosin Beta-4 (Wolverine 10/10 blend) | HPLC purity | PASS | 99.41% | Freedom Diagnostics | Lot 26062101 · Report 2606250169 |
| Jun 3, 2026 | GHK-Cu | HPLC purity | PASS | 99.48% | Horizon Analytical | Lot PP-6524116-P · Report PP-6524116-P |
| May 26, 2026 | TB-500 | HPLC purity | PASS | 99.521% |
Research profiles — side effects, mechanism, and lab-tested COA data for each peptide in this vendor's catalog.
Add a live, data-driven trust badge to your site or review. It updates automatically when new COAs are indexed — no account required.
Preview
Live badge (JavaScript)
<script async src="https://www.disclosedlabs.com/widget.js" data-vendor="prime-peptides"></script>
Renders the dynamic grade badge. Best visual; the link is injected by script.
Static link (HTML) — best for SEO
<a href="https://www.disclosedlabs.com/vendors/primepeptides.co" rel="noopener" target="_blank" style="display:inline-flex;align-items:center;gap:8px;padding:8px 12px;border:1px solid #e2e8f0;border-radius:10px;background:#fff;color:#0f172a;text-decoration:none;font:600 13px/1.25 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif"> COA Trust Score by Disclosed Labs — independent index of published COAs </a>
A plain, crawlable dofollow link in your page source. This is the version search engines credit.
Both point to Prime Peptides's live profile at https://www.disclosedlabs.com/vendors/primepeptides.co.
Links back to Prime Peptides's profile — a dofollow link (no sponsored or nofollow tagging). Score updates daily. Dark theme & options →
| BPC-157 | vial | 10mg | $60.00 | $6.00 | In stock | 2026-07-08 | View → |
| BPC-157 + TB-500 | blend | 20mg | $50.00 | $2.50 | In stock | 2026-07-08 | View → |
| GHK-Cu | vial | 100mg | $65.00 | $0.65 | In stock | 2026-07-08 | View → |
| Ipamorelin | vial | 10mg | $55.00 | $5.50 | In stock | 2026-07-08 | View → |
| Melanotan I | vial | 10mg | $45.00 | $4.50 | In stock | 2026-07-08 | View → |
| MOTS-c | vial | 10mg | $55.00 | $5.50 | In stock | 2026-07-08 | View → |
| NAD+ | vial | 1000mg | $125.00$150.00 | $0.13 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 10mg | $120.00 | $12.00 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 30mg | $265.00 | $8.83 | In stock | 2026-07-08 | View → |
| Retatrutide | vial | 60mg | $450.00 | $7.50 | In stock | 2026-07-08 | View → |
| Semaglutide | vial | 5mg | $80.00 | $16.00 | In stock | 2026-07-08 | View → |
| Semaglutide | vial | 10mg | $110.00 | $11.00 | In stock | 2026-07-08 | View → |
| Semaglutide | vial | 15mg | $130.00 | $8.67 | In stock | 2026-07-08 | View → |
| Semax | vial | 10mg | $50.00 | $5.00 | In stock | 2026-07-08 | View → |
| Semax + Selank | blend | 20mg | $90.00 | $4.50 | In stock | 2026-07-08 | View → |
| Sermorelin | vial | 10mg | $65.00 | $6.50 | In stock | 2026-07-08 | View → |
| TB-500 | vial | 10mg | $75.00 | $7.50 | In stock | 2026-07-08 | View → |
| Tesamorelin | vial | 10mg | $60.00$70.00 | $6.00 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 10mg | $115.00 | $11.50 | In stock | 2026-07-08 | View → |
| Tirzepatide | vial | 30mg | $170.00 | $5.67 | Sold out | 2026-07-08 | View → |
| Tirzepatide | vial | 60mg | $280.00 | $4.67 | In stock | 2026-07-08 | View → |
Prices are scraped from primepeptides.coand may lag the live site. All prices are single-vial / pre-bulk list prices — bulk or bundle deals may be lower. $/mg is derived from the listed strength. “Updated” is when we last verified each listing.
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v16). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 53 COAs attributed to this vendor. Last recomputed 2026-07-06.
PMB address (-0.03), Non-fixed VoIP phone (-0.04), Full identity on file (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Janoshik Analytical |
| Lot 4142026TB · Report 163763 |
| May 26, 2026 | AOD-9604 | HPLC purity | PASS | 99.45% | Janoshik Analytical | Lot 4132026AD · Report 163765 |
| May 25, 2026 | NAD+ | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 4112026ND · Report 163759 |
| May 18, 2026 | Retatrutide | HPLC purity | PASS | 99.53% | Janoshik Analytical | Lot 4032026RT · Report 156386 |
| May 15, 2026 | MOTS-C | HPLC purity | PASS | 98.732% | Janoshik Analytical | Lot 4052026MO · Report 156389 |
| May 15, 2026 | BPC-157 | HPLC purity | PASS | 99.814% | Janoshik Analytical | Lot 4042026BP · Report 156387 |
| May 15, 2026 | Klow Blend Blue Cap | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 4022026KLO · Report 156393 |
| May 15, 2026 | TB-500 | HPLC purity | PASS | 98.893% | Janoshik Analytical | Lot 4062026TB · Report 156391 |
| May 11, 2026 | Retatrutide | HPLC purity | PASS | 99.203% | Janoshik Analytical | Lot 3302026RT · Report 154305 |
| May 11, 2026 | Ipamorelin | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 3292026CJI · Report 154307 |
| Apr 28, 2026 | Tirzepatide | HPLC purity | PASS | 99.815% | Janoshik Analytical | Lot 3082026TR · Report 150106 |
| Apr 28, 2026 | Semaglutide | HPLC purity | PASS | 99.751% | Janoshik Analytical | Lot 3142026SM · Report 150102 |
| Apr 28, 2026 | Glow Blend Green Cap | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 3302026GLO · Report 150112 |
| Apr 28, 2026 | Tirzepatide | HPLC purity | PASS | 99.879% | Janoshik Analytical | Lot 3112026TR · Report 150104 |
| Apr 28, 2026 | Melanotan II | HPLC purity | PASS | 99.967% | Janoshik Analytical | Lot 3092026MT2 · Report 150110 |
| Apr 28, 2026 | GHK-Cu | HPLC purity | PASS | 99.034% | Janoshik Analytical | Lot 3102026GK · Report 150114 |
| Apr 28, 2026 | Melanotan II | HPLC purity | PASS | 99.732% | Janoshik Analytical | Lot 3132026MT2 · Report 150108 |
| Apr 28, 2026 | Semaglutide | HPLC purity | PASS | 99.862% | Janoshik Analytical | Lot 3022026SM · Report 150100 |
| Apr 28, 2026 | Semaglutide | HPLC purity | PASS | 99.172% | Janoshik Analytical | Lot 2242026SM · Report 150098 |
| Apr 22, 2026 | Ipamorelin | HPLC purity | PASS | 99.8% | Bioviridian | Lot 3162026IPA · Report COA3940 |
| Apr 22, 2026 | Klow Blend 80mg | HPLC purity | PASS | 99.7% | Bioviridian | Lot 3182026KLO |
| Apr 22, 2026 | Tirzepatide | HPLC purity | PASS | 99.8% | Bioviridian | Lot 3122026TR · Report COA3939 |
| Apr 22, 2026 | Retatrutide | HPLC purity | PASS | 99.8% | Bioviridian | Lot 3172026RT · Report COA3942 |
| Apr 22, 2026 | Retatrutide | HPLC purity | PASS | 99.8% | Bioviridian | Lot 3202026RT · Report COA3941 |
| Apr 22, 2026 | Glutathione | HPLC purity | PASS | 99.8% | Bioviridian | Lot 3152026GLU |
| Apr 10, 2026 | Semaglutide | HPLC purity | PASS | 99.681% | Janoshik Analytical | Lot 3272026SM · Report 133988 |
| Apr 10, 2026 | Semaglutide | HPLC purity | PASS | 99.625% | Janoshik Analytical | Lot 3222026SX · Report 133989 |
| Mar 30, 2026 | Semaglutide | HPLC purity | PASS | 99.41% | AccumarkLabs | Lot 2182026SM · Report AUDC-H32M |
| Mar 25, 2026 | NAD+ | HPLC purity | PASS | 99.8% | Bioviridian | Lot 2172026ND |
| Mar 24, 2026 | MOTS-C | HPLC purity | PASS | 99.05% | Vanguard Laboratory | Lot 11242025MO · Report V260316-18 004 |
| Mar 24, 2026 | Semaglutide | HPLC purity | PASS | 99.02% | Vanguard Laboratory | Lot 2122026SM · Report V260316-18 001 |
| Mar 6, 2026 | BPC-157 | HPLC purity | PASS | 99.943% | Janoshik Analytical | Lot 01162026BP · Report 112519 |
| Mar 5, 2026 | Retatrutide | HPLC purity | PASS | 99.819% | Janoshik Analytical | Lot 1102026RT · Report 112521 |
| Feb 17, 2026 | Klow Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 1032026KLO · Report 107696 |
| Feb 17, 2026 | Glow Blend | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 1132026GLO · Report 107697 |
| Feb 16, 2026 | Retatrutide | HPLC purity | PASS | 99.382% | Janoshik Analytical | Lot 10172025RT · Report 107694 |
| Feb 16, 2026 | Tirzepatide | HPLC purity | PASS | 99.895% | Janoshik Analytical | Lot 01262026TR · Report 107699 |
| Feb 16, 2026 | Semaglutide | HPLC purity | PASS | 99.524% | Janoshik Analytical | Lot 1052026SM · Report 107695 |
| Feb 16, 2026 | Sermorelin | HPLC purity | PASS | 99.796% | Janoshik Analytical | Lot 01222026SR · Report 107698 |
| Jan 27, 2026 | AOD-9604 | HPLC purity | PASS | 99.627% | Janoshik Analytical | Lot 01062026 · Report 101415 |
| Jan 23, 2026 | GHK-Cu | HPLC purity | PASS | 99.64% | Janoshik Analytical | Lot 112520256K · Report 101414 |
| Jan 23, 2026 | BPC-157 | HPLC purity | PASS | 99.301% | Janoshik Analytical | Lot 12042025BP · Report 101418 |
| Jan 22, 2026 | Semaglutide | HPLC purity | PASS | 99.791% | Janoshik Analytical | Lot 11092025SM · Report 101413 |
| Jan 22, 2026 | Tirzepatide | HPLC purity | PASS | 99.85% | Janoshik Analytical | Lot 01072026TR · Report 101420 |
| Dec 11, 2025 | Tesamorelin | HPLC purity | PASS | 99.242% | Janoshik Analytical | Lot 11022025TM · Report 92726 |
| Dec 11, 2025 | Ipamorelin | HPLC purity | PASS | 99.801% | Janoshik Analytical | Lot 10232025IPA · Report 92724 |
| Nov 20, 2025 | TB-500 | HPLC purity | PASS | 99.289% | Janoshik Analytical | Lot 10162025TB · Report 89285 |
| Sep 29, 2025 | Selank/Semax | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot 8272025SSX · Report 80492 |
Disclosed Labs